China NMPA Drug Inspection - Shanghai STA Pharmaceutical Product Co., Ltd. - Hawthorn (labeled as raw hawthorn)
China NMPA drug inspection for Shanghai STA Pharmaceutical Product Co., Ltd. published June 11, 2018. Drug: Hawthorn (labeled as raw hawthorn). The Shanghai Municipal Food and Drug Administration (Shanghai FDA) released its 2018 Issue 5 Drug Supervision and Sampli
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanghai STA Pharmaceutical Product Co., Ltd. published June 11, 2018. Drug: Hawthorn (labeled as raw hawthorn). The Shanghai Municipal Food and Drug Administration (Shanghai FDA) released its 2018 Issue 5 Drug Supervision and Sampli
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox